These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30462233)

  • 21. Digitalis Therapy and Risk of Recurrent Ventricular Tachyarrhythmias and ICD Therapies in Atrial Fibrillation and Heart Failure.
    Schupp T; Behnes M; Weiss C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Weidner K; Akin M; Mashayekhi K; Borggrefe M; Akin I
    Cardiology; 2019; 142(3):129-140. PubMed ID: 31189160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
    Kosiuk J; Nedios S; Darma A; Rolf S; Richter S; Arya A; Piorkowski C; Gaspar T; Sommer P; Husser D; Hindricks G; Bollmann A
    Europace; 2014 Sep; 16(9):1322-6. PubMed ID: 24532559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
    Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.
    Biffi M; Iori M; De Maria E; Bolognesi MG; Placci A; Calvi V; Allocca G; Ammendola E; Carinci V; Boggian G; Saporito D; Grassini D; Giacopelli D; Statuto G; Ziacchi M
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):846-853. PubMed ID: 32064713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients ≥ 60 Years with Implantable Cardioverter Defibrillator.
    Abugroun A; Elawad A; Okoh AK; Abdel-Rahman ME; Ayinde H; Volgman AS
    Am J Cardiol; 2021 Aug; 152():94-98. PubMed ID: 34090659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure.
    Bertini M; Borleffs CJ; Delgado V; Ng AC; Piers SR; Shanks M; Antoni ML; Biffi M; Boriani G; Schalij MJ; Bax JJ; Van de Veire NR
    Eur J Heart Fail; 2010 Oct; 12(10):1101-10. PubMed ID: 20861134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators.
    Chang IC; Agamawi YM; Austin E; Adkisson WO; Roukoz H; von Wald LN; Sakaguchi S; Benditt DG; Chen LY
    Am J Cardiol; 2016 Nov; 118(10):1497-1502. PubMed ID: 27649879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
    Simpson J; Castagno D; Doughty RN; Poppe KK; Earle N; Squire I; Richards M; Andersson B; Ezekowitz JA; Komajda M; Petrie MC; McAlister FA; Gamble GD; Whalley GA; McMurray JJ;
    Eur J Heart Fail; 2015 Nov; 17(11):1182-91. PubMed ID: 26358762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial.
    Bogdan S; Glikson M; Connolly SJ; Wang J; Hohnloser SH; Appl U; Neuzener J; Mabo P; Vinolas X; Gadler F; van Erven L; Kautzner J; Meeks B; Pogue J; Healey JS
    Heart Rhythm; 2019 Jan; 16(1):83-90. PubMed ID: 30063996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable defibrillator-detected heart failure status predicts atrial fibrillation occurrence.
    Bertini M; Vitali F; Santini L; Tavoletta V; Giano A; Savarese G; Russo AD; Santobuono VE; Mattera A; Lavalle C; Amellone C; Pecora D; Calvanese R; Rapacciuolo A; Campari M; Valsecchi S; Calò L
    Heart Rhythm; 2022 May; 19(5):790-797. PubMed ID: 35066184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial Rate-Responsive Pacing and Incidence of Sustained Atrial Arrhythmias in Patients with Implantable Cardioverter Defibrillators.
    Fontenla A; Salguero R; Martinez-Ferrer JB; Rodriguez A; Alzueta J; Garcia E; Basterra N; Romero R; Concha JF; Viñolas X; Villacastin J; Lopez-Gil M; Arribas F
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):548-56. PubMed ID: 27001125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.
    Jobs A; Schwind J; Katalinic A; Babaev V; Tilz RR; Rausch S; Thiele H; Eitel I; Eitel C
    Clin Res Cardiol; 2019 Jan; 108(1):74-82. PubMed ID: 29987595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure.
    Mountantonakis SE; Grau-Sepulveda MV; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):191-201. PubMed ID: 22361078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation.
    Zareba W; Steinberg JS; McNitt S; Daubert JP; Piotrowicz K; Moss AJ;
    Heart Rhythm; 2006 Jun; 3(6):631-7. PubMed ID: 16731460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.